A. Ahmedova Et Al. , "Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients.," 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET , vol.35, Illinois, United States Of America, 2017
Ahmedova, A. Et Al. 2017. Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients.. 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET , (Illinois, United States Of America).
Ahmedova, A., Ozkaya, K., Tambas, M., Gezer, U., Ozgur, E., Sahin, D., ... Sanli, Y.(2017). Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients. . 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America
Ahmedova, Aysel Et Al. "Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients.," 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2017
Ahmedova, Aysel Et Al. "Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients.." 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET , Illinois, United States Of America, 2017
Ahmedova, A. Et Al. (2017) . "Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients.." 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Aysel Ahmedova Et Al. }, title={Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients.}, congress name={53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET}, city={Illinois}, country={United States Of America}, year={2017}}